University of Tsukuba


The University of Tsukuba is located in the suburbs of Tokyo and is at the heart of Tsukuba Science City —Japan’s largest “science city,” which has 29 national research institutes and about 150 private research organizations. The University operates on the principle that it is open to all.

The University of Tsukuba aims to cross the borders that separate a variety of organizations, such as those between nations, research institutions, and fields of study. The University’s network is expanding globally. In particular, the University has entered into ten campus-in-campus arrangements with universities in eight countries and regions, thereby promoting close cooperative relationships between education and research. At present, the University hosts approximately 2,200 study abroad students from more than 110 countries and regions.

Collaboration is essential in order to achieve high-quality outcomes with limited resources. As an example, the University is actively engaged in an exchange of talent and joint research that goes beyond the conventional university framework at nationwide joint-use institutes that encompass the four fields of computational science, marine science, plant science, and plasma research.

The Research and Development Centers are the part of the University’s quest to pursue research and innovation that result in benefits for society. Externally funded, twelve centers are newly established as industry-university-government partnerships for joint research in areas of high demand from the community.

The University is also proactively engaging in the support of venture corporations. Thus far, a total of 160 companies have originated from the University of Tsukuba, including Cyberdyne, Inc.

A frontrunner in university reform in Japan, the University is creating a flexible education and research structure as well as a university system to meet the needs of the next generation. It aspires to be a comprehensive university, continuously meeting new challenges and developing new areas. The foremost mission of a university is to provide an environment that allows future leaders to realize their full potential. The University gives students the opportunity to develop their individuality and skills through an education that is backed by cutting-edge research.

The University of Tsukuba retains sole responsibility for content. © 2021 The University of Tsukuba.

1 December 2019 - 30 November 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for University of Tsukuba published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
233 47.37

Outputs by subject (Share)

Subject Count Share
Physical Sciences 128 15.44
Chemistry 46 13.89
Life Sciences 68 16.45
Earth & Environmental Sciences 14 5.04

Highlight of the month

Dangerous drug could lead to safe sleeping pills

© Peter Dazeley/The Image Bank/Getty Images

© Peter Dazeley/The Image Bank/Getty Images

The sleep-promoting effects of thalidomide involve a different molecular pathway than the one responsible for the drug’s most notorious side effect, a mouse study has found.

Thalidomide was once used to treat morning sickness in pregnant women until it was found to cause birth defects. Thalidomide’s toxicity occurs because of the drug’s binding to a protein called cereblon, a key regulator of the cell’s rubbish-disposal system.

Now, a team led by researchers at the University of Tsukuba in Japan has found that it may be possible to chemically modify the drug such that it does not interfere with foetal development but keeps its anti-insomnia benefits.

Using mice that produced a thalidomide-resistant version of cereblon, the researchers found that the drug still enhanced sleep — in particular, a desirable type of slumber known as non-REM sleep. This indicates that thalidomide’s sleep-promoting effects are independent of cereblon. Future thalidomide-like agents that avoid cereblon-binding entirely could thus offer a safe option for treating insomnia.

Supported content

  1. PNAS 117, 23106–23112 (2020). doi: 10.1073/pnas.1917701117

View the article on the Nature Index

See more research highlights from University of Tsukuba

More research highlights from University of Tsukuba

1 December 2019 - 30 November 2020

International vs. domestic collaboration by Share

  • 41.91% Domestic
  • 58.09% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (163 total)

  • University of Tsukuba, Japan
  • Domestic institution
  1. The University of Tokyo (UTokyo), Japan (18.07)
  2. RIKEN, Japan (13.61)
  3. National Institute of Advanced Industrial Science and Technology (AIST), Japan (12.01)
  4. National Institute for Materials Science (NIMS), Japan (11.15)
  5. Kyoto University, Japan (8.41)
  6. Tohoku University, Japan (7.80)
  7. Osaka University, Japan (4.82)
  8. Kyushu University, Japan (4.35)
  9. Hokkaido University, Japan (3.90)
  10. Keio University, Japan (3.24)

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Affiliated joint institutions and consortia

Return to institution outputs